TIA — Transient Ischemic Attack (Mini-Stroke)

Table of Contents

1. What is a TIA?
2. TIA vs Stroke: Key Differences
3. FAST Warning Signs
4. ABCD2 Score — Predicting Stroke Risk
5. Risk Factors
6. Urgent Diagnosis
7. Same-Day TIA Clinic — The EXPRESS Trial
8. Acute Management
9. Secondary Prevention
10. Lifestyle and Natural Approaches
11. Key Research Papers
12. Connections
13. Featured Videos

Back to Table of Contents

What is a TIA?

A transient ischemic attack (TIA) — commonly called a "mini-stroke" — is a brief episode of neurological dysfunction caused by temporary loss of blood flow to a part of the brain, spinal cord, or retina, without causing permanent infarction. Symptoms resolve completely, usually within minutes to an hour, and virtually always within 24 hours.

The term "mini-stroke" is dangerously misleading because it implies TIA is minor. In reality, a TIA is a medical emergency. Within 48 hours of a TIA, roughly 5% of patients will have a full stroke — and within 90 days, 10–15% will have a disabling or fatal stroke. Urgent evaluation and treatment can reduce that 90-day risk by more than 80%.

Approximately 240,000 TIAs are diagnosed annually in the United States, though the true number is likely higher because many patients dismiss mild or fleeting symptoms and do not seek care.

Back to Table of Contents

TIA vs Stroke: Key Differences

The distinction between TIA and ischemic stroke was historically based on duration — symptoms lasting less than 24 hours were called TIA. The modern tissue-based definition is more precise:

• TIA (tissue-based definition): Transient neurological symptoms with no infarction on brain imaging (DWI-MRI negative or shows no new lesion). Symptoms typically resolve within 1 hour in most true TIAs.
• Minor ischemic stroke: Symptoms resolve, but DWI shows a small area of permanent infarction. NIHSS score ≤3–5. Often treated identically to TIA in the acute phase.
• Ischemic stroke: Persistent neurological deficit with infarction on imaging.

Clinically, this distinction matters because up to 40% of events meeting the old "symptoms resolved within 24 hours" definition actually show infarction on MRI — meaning they were minor strokes, not true TIAs. These patients have higher early recurrence risk than pure TIAs without imaging evidence of infarction.

Back to Table of Contents

FAST Warning Signs

TIA produces the same warning signs as stroke — the critical difference is that they resolve. Never wait to see if symptoms go away before calling 911 — you cannot distinguish a TIA from a stroke in the first minutes:

• F — Face drooping: One side of the face droops or feels numb. Uneven smile.
• A — Arm weakness: One arm is weak, numb, or drifts downward when both are raised.
• S — Speech difficulty: Slurred, garbled, wrong-word substitutions, or inability to speak or understand others.
• T — Time to call 911: Even if symptoms resolve during the 911 call, go to the emergency department immediately.

Additional TIA symptoms include sudden monocular vision loss (amaurosis fugax — like a shade being pulled over one eye), sudden loss of sensation on one side, sudden severe dizziness or loss of balance, and sudden confusion or memory gap.

Amaurosis fugax (temporary blindness in one eye) is a classic TIA variant from retinal artery embolism originating in the ipsilateral carotid artery. It resolves within minutes and strongly predicts carotid artery disease.

Back to Table of Contents

ABCD2 Score — Predicting Stroke Risk After TIA

The ABCD2 score is a validated clinical tool that estimates the 2-day and 7-day risk of stroke after a TIA. It helps triage urgency of workup and treatment:

• A — Age ≥60 years: 1 point
• B — Blood pressure ≥140/90 mmHg at presentation: 1 point
• C — Clinical features:
  • Unilateral weakness: 2 points
  • Speech disturbance without weakness: 1 point
  • Other symptoms: 0 points
• D — Duration of symptoms:
  • ≥60 minutes: 2 points
  • 10–59 minutes: 1 point
  • <10 minutes: 0 points
• D — Diabetes: 1 point

Total score interpretation:

• 0–3 (low): 1.0% 2-day stroke risk
• 4–5 (moderate): 4.1% 2-day stroke risk
• 6–7 (high): 8.1% 2-day stroke risk

Important caveat: The ABCD2 score has limitations and should not be used to delay workup or defer hospital admission in patients with first TIA. Current guidelines recommend urgent evaluation (ideally same-day) for all TIA patients regardless of ABCD2 score.

Back to Table of Contents

Risk Factors

• Hypertension: Present in 60–70% of TIA patients. Systolic BP above 140 mmHg is the strongest modifiable risk factor for TIA and subsequent stroke.
• Atrial fibrillation: Causes cardioembolic TIA through clot formation in the left atrial appendage. May be paroxysmal and go undetected on standard ECG — requires prolonged monitoring.
• Carotid artery stenosis: Atherosclerotic plaque in the ipsilateral internal carotid artery causes artery-to-artery embolism to the hemispheric or retinal arteries.
• Diabetes: Doubles risk through accelerated atherogenesis and hypercoagulability.
• Smoking: Doubles TIA and stroke risk; synergizes with oral contraceptive use in young women.
• Dyslipidemia: Elevated LDL accelerates carotid and intracranial atherosclerosis.
• Patent foramen ovale (PFO): In young patients with cryptogenic TIA/stroke, PFO allows paradoxical embolism of venous thrombi into the arterial circulation. PFO closure is beneficial in selected young patients (CLOSE, REDUCE trials).
• Prior TIA: One TIA markedly increases the risk of future TIA and stroke — making secondary prevention urgent after the very first event.

Back to Table of Contents

Urgent Diagnosis

TIA workup must be completed urgently — ideally within 24 hours — because the highest risk of stroke is in the first 48 hours. Delays allow preventable strokes to occur.

• Brain MRI with DWI: The definitive test to determine whether infarction occurred. Superior to CT for detecting small or posterior fossa lesions. Should be performed within 24 hours of symptom onset.
• CT/CTA: Rapid non-contrast CT to exclude hemorrhage; CTA to evaluate carotid and intracranial arteries for stenosis or occlusion. Available around the clock in most emergency departments.
• Carotid imaging: Carotid ultrasound, CTA, or MRA to detect ipsilateral stenosis. Symptomatic carotid stenosis ≥50% changes management (endarterectomy or stenting).
• 12-lead ECG: Immediate — looking for atrial fibrillation, flutter, or recent myocardial infarction.
• Prolonged cardiac monitoring: Holter monitor (24–48 hours) or implantable loop recorder (30 days) detects paroxysmal AF in 10–20% of cryptogenic TIA/stroke patients. The CRYSTAL-AF trial showed 30-day loop recorder more than doubled AF detection versus conventional monitoring.
• Laboratory workup: Complete blood count (polycythemia, thrombocytosis), coagulation studies, fasting lipid panel, HbA1c, and in young patients: hypercoagulable states (antiphospholipid syndrome, factor V Leiden, protein C/S deficiency).
• Echocardiography: Transthoracic echo for structural heart disease; transesophageal echo superior for detecting PFO, left atrial appendage thrombus, and aortic arch atheroma.

Back to Table of Contents

Same-Day TIA Clinic — The EXPRESS Trial

The EXPRESS trial (Early use of eXisting PREventive Strategies for Stroke, published 2007) is one of the most important pragmatic trials in stroke medicine. It demonstrated that organizing care around a same-day TIA clinic with immediate initiation of preventive treatment — rather than the traditional "wait for outpatient neurology" approach — dramatically reduces early stroke risk.

In the trial, patients who received same-day evaluation and started treatment immediately had a 90-day stroke risk of 2.1% versus 10.3% in the control period — an 80% relative risk reduction. This represents one of the largest absolute risk reductions ever achieved in preventive neurology.

Key elements of the EXPRESS approach:

• Immediate aspirin (or dual antiplatelet) on presentation
• Same-day imaging (brain MRI and vascular imaging)
• Same-day specialist review
• Immediate initiation of antihypertensive therapy if blood pressure is elevated
• Early statin initiation

This trial changed guidelines worldwide. Current American Heart Association/American Stroke Association guidelines recommend that all TIA patients be evaluated urgently, with high-ABCD2 patients seen within 24 hours and ideally admitted for expedited workup.

Back to Table of Contents

Acute Management

Unlike ischemic stroke, tPA is generally not indicated for TIA because symptoms have resolved and there is no demonstrated ischemic tissue to salvage. However, acute management is still urgent:

• Antiplatelet therapy: Aspirin 300–325 mg loading dose should be given immediately (if hemorrhage excluded on imaging). This is then continued at 75–100 mg daily.
• Dual antiplatelet therapy (DAPT): For minor stroke or high-risk TIA (ABCD2 ≥4), aspirin plus clopidogrel for 21 days (CHANCE trial) or up to 90 days (POINT trial) reduces early recurrence by approximately 25–30% compared to aspirin alone. After this period, monotherapy is preferred to reduce bleeding risk.
• Blood pressure management: Avoid aggressive acute lowering in the first 24 hours (may reduce perfusion in borderline ischemic territory). After 24 hours, begin or intensify antihypertensive therapy to target below 130/80 mmHg.
• Carotid endarterectomy (CEA): For symptomatic carotid stenosis ≥50–70%, CEA performed within 2 weeks of the TIA provides maximum benefit. Delaying surgery beyond 2 weeks loses most of the protective effect.
• Anticoagulation for AF: If atrial fibrillation is identified, initiate DOAC (preferred over warfarin) as soon as it is safe — often within 2–7 days after minor TIA, balancing hemorrhagic transformation risk against recurrent cardioembolic events.

Back to Table of Contents

Secondary Prevention

Long-term prevention after TIA mirrors stroke secondary prevention:

• Antiplatelet therapy (non-cardioembolic): Aspirin monotherapy 75–100 mg daily remains standard after the initial DAPT window. Clopidogrel 75 mg daily is an alternative for aspirin-intolerant patients and may be slightly more effective (CAPRIE trial, 8.7% vs 9.4% annual event rate).
• Anticoagulation (cardioembolic/AF): DOAC (apixaban, rivaroxaban, dabigatran) long-term for AF-related TIA. INR-targeted warfarin if DOAC is contraindicated.
• High-intensity statin: Atorvastatin 80 mg or rosuvastatin 40 mg regardless of baseline LDL. Reduces recurrent events by 16–25%.
• Blood pressure control: Target systolic below 130 mmHg. ACE inhibitors (especially perindopril) and thiazide diuretics have the strongest evidence in secondary stroke/TIA prevention (PROGRESS trial).
• Glucose control in diabetics: HbA1c target below 7%; avoids hypoglycemia (which can trigger neurological symptoms mimicking TIA).
• PFO closure: In patients under 60 with cryptogenic TIA/minor stroke and a large or moderate PFO with atrial septal aneurysm, device closure reduces recurrence compared to antiplatelet therapy alone (CLOSE trial).

Back to Table of Contents

Lifestyle and Natural Approaches

TIA is a powerful warning signal — patients who act on it aggressively with lifestyle changes can dramatically reduce their future stroke risk:

• Mediterranean diet: Reduces vascular events by 30% in the PREDIMED trial. Provides anti-inflammatory polyphenols, omega-3 fatty acids, and potassium — all beneficial for endothelial function and blood pressure.
• Regular aerobic exercise: 150 minutes per week of moderate activity reduces blood pressure, improves lipid profile, reduces AF burden, and lowers body weight. All translate directly to reduced stroke risk.
• Smoking cessation: Single most impactful modifiable risk factor in many patients. Risk returns to near-baseline within 5 years. Use combination pharmacotherapy (varenicline + NRT) for best quit rates.
• Alcohol reduction: Limit to ≤1 drink/day for women, ≤2/day for men. Heavier drinking causes hypertension, atrial fibrillation, and thrombocytopenia — all stroke risk factors.
• Weight management: Even modest 5–10% weight loss significantly reduces blood pressure, improves insulin sensitivity, and reduces AF burden in overweight individuals.
• Omega-3 fatty acids: EPA/DHA from fatty fish or supplements reduce triglycerides and cardiovascular risk. Particularly beneficial for patients with elevated triglycerides above 500 mg/dL (REDUCE-IT trial).
• DASH diet: Dietary Approaches to Stop Hypertension reduces systolic BP by 8–14 mmHg — comparable to a single antihypertensive medication. High in potassium, calcium, magnesium, and low in sodium.

Back to Table of Contents

Key Research Papers

Pivotal trials that define modern TIA management:

1. Rothwell PM et al., 2007 — EXPRESS Trial: Effect of urgent TIA treatment on early stroke risk. PMID: 17928588
2. Johnston SC et al., 2007 — ABCD2 score validation for TIA-to-stroke risk prediction. PMID: 17050893
3. Wang Y et al., 2013 — CHANCE Trial: Clopidogrel + aspirin vs aspirin for minor stroke or TIA. PMID: 26196118
4. Johnston SC et al., 2018 — POINT Trial: Clopidogrel + aspirin vs aspirin after TIA/minor stroke. PMID: 29766750
5. Kernan WN et al., 2014 — AHA/ASA Guidelines for Prevention of Stroke in TIA Patients. PMID: 24291937
6. Sanna T et al., 2014 — CRYSTAL-AF: Prolonged cardiac monitoring after TIA/cryptogenic stroke. PMID: 26803056
7. Mas JL et al., 2017 — CLOSE Trial: PFO closure vs antiplatelet therapy for cryptogenic stroke. PMID: 28601962
8. CAPRIE Steering Committee, 1996 — Clopidogrel vs aspirin in patients at risk of ischemic events. PMID: 8622248
9. PROGRESS Collaborative Group, 2001 — Perindopril in secondary prevention of stroke. PMID: 11274623
10. Amarenco P et al., 2006 — SPARCL: Atorvastatin 80 mg after stroke or TIA. PMID: 16441422
11. Bhatt DL et al., 2019 — REDUCE-IT: Icosapentaenoic acid for cardiovascular risk reduction. PMID: 30404111

Back to Table of Contents

Connections

• Stroke (Ischemic and Hemorrhagic)
• Atrial Fibrillation
• Hypertension
• Atherosclerosis
• Epilepsy
• Alzheimer's Disease
• Peripheral Neuropathy
• Type 2 Diabetes
• Magnesium
• Potassium
• Vitamin D3
• Vitamin B12
• Mediterranean Diet
• Salmon
• POTS
• Bell's Palsy

Back to Table of Contents

×

Featured Videos